Xylyx Bio, a regenerative medicine company, and Alec Batis, a renowned product innovator and research chemist, have formed a strategic collaboration to bring Sweet Chemistry Evidence-Based Regenerative Skincare to market.

Xylyx Bio's pioneering biotechnology combined with Batis' world-class formulation expertise creates a game-changing partnership at the nexus of regenerative medicine and cosmetic science.

Sweet Chemistry will launch on its website this summer with two products.

Following a clinical trial, Xylyx Bio’s Matrikyne ingredient was deemed efficacious in combatting anti-aging effects and improving skin appearance.

Independent clinical study results validate Matrikynes® efficacy in reversing common signs of skin damage and aging, including reduction of lines and wrinkles.

Improved approaches to expanding the pool of donor lungs suitable for transplantation are critically needed for the growing population with end-stage lung disease.

Xenogeneic cross-circulation (XC) is an experimental method for ex vivo organ support and recovery that could expand the pool of donor lungs suitable for transplantation. The objective of this study was to establish and validate...

Study demonstrates that a novel technique for regenerating donor lungs can increase the number of organs available for life-saving transplantation